Skip to content

Clinical trials

Phase 2 Retinal Vein Occlusion trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Vein Occlusion Phase: Phase 2 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20093
20103
20121
20132
20156
20171
20192
20212
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status8
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shahid Beheshti University of Medical Sciences3
Annexin Pharmaceuticals AB2
Manhattan Eye, Ear & Throat Hospital2
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2
Aerie Pharmaceuticals1
Aerpio Therapeutics1
Alimera Sciences1
Allergan1
Assaf-Harofeh Medical Center1
Barnes Retina Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Vein Occlusion30
Macular Edema12
Diabetic Retinopathy5
Macular Degeneration4
Retinal Neovascularization2
Wet Macular Degeneration2
Choroidal Neovascularization1
Communicable Diseases1
Diabetes Mellitus1
Geographic Atrophy1

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.